|
Name |
Sebacic acid, octyl 2-propylpentyl ester
|
Molecular Formula | C26H50O4 | |
IUPAC Name* |
1-O-octyl 10-O-(2-propylpentyl) decanedioate
|
|
SMILES |
CCCCCCCCOC(=O)CCCCCCCCC(=O)OCC(CCC)CCC
|
|
InChI |
InChI=1S/C26H50O4/c1-4-7-8-9-14-17-22-29-25(27)20-15-12-10-11-13-16-21-26(28)30-23-24(18-5-2)19-6-3/h24H,4-23H2,1-3H3
|
|
InChIKey |
BMDODQXZPAGMPV-UHFFFAOYSA-N
|
|
Synonyms |
Sebacic acid, octyl 2-propylpentyl ester
|
|
CAS | NA | |
PubChem CID | 91729477 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 426.7 | ALogp: | 9.3 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 24 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 52.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 30 | QED Weighted: | 0.127 |
Caco-2 Permeability: | -4.748 | MDCK Permeability: | 0.00001490 |
Pgp-inhibitor: | 0.026 | Pgp-substrate: | 0.012 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.994 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.027 | Plasma Protein Binding (PPB): | 95.53% |
Volume Distribution (VD): | 1.558 | Fu: | 1.36% |
CYP1A2-inhibitor: | 0.13 | CYP1A2-substrate: | 0.17 |
CYP2C19-inhibitor: | 0.348 | CYP2C19-substrate: | 0.06 |
CYP2C9-inhibitor: | 0.143 | CYP2C9-substrate: | 0.863 |
CYP2D6-inhibitor: | 0.541 | CYP2D6-substrate: | 0.032 |
CYP3A4-inhibitor: | 0.509 | CYP3A4-substrate: | 0.083 |
Clearance (CL): | 7.17 | Half-life (T1/2): | 0.24 |
hERG Blockers: | 0.385 | Human Hepatotoxicity (H-HT): | 0.033 |
Drug-inuced Liver Injury (DILI): | 0.281 | AMES Toxicity: | 0.002 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.965 | Carcinogencity: | 0.083 |
Eye Corrosion: | 0.947 | Eye Irritation: | 0.867 |
Respiratory Toxicity: | 0.372 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000601 | 0.728 | D00MLW | 0.594 | ||||
ENC000595 | 0.641 | D07ILQ | 0.436 | ||||
ENC001218 | 0.624 | D0Z5SM | 0.418 | ||||
ENC001234 | 0.611 | D00FGR | 0.416 | ||||
ENC000765 | 0.600 | D00AOJ | 0.394 | ||||
ENC003063 | 0.596 | D0Z1QC | 0.393 | ||||
ENC001369 | 0.560 | D05ATI | 0.389 | ||||
ENC000419 | 0.543 | D0T9TJ | 0.386 | ||||
ENC000575 | 0.543 | D0O1PH | 0.385 | ||||
ENC000258 | 0.542 | D0AY9Q | 0.351 |